Biotechnology Assets Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 7, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17	18	23	12	21	22
Market Cap Growth	-21.43%	-20.03%	84.02%	-40.67%	-3.86%	-72.86%
Enterprise Value	19	20	26	19	24	84
Last Close Price	0.23	0.28	0.40	0.23	0.46	0.56
PE Ratio	-	-	14.53	-	-	-
Forward PE	-	2.25	2.25	2.25	2.25	2.25
PS Ratio	5.57	6.17	5.85	4.20	6.38	7.53
PB Ratio	2.64	2.77	3.50	3.21	4.83	5.67
P/TBV Ratio	3.78	4.32	6.64	-	-	-
P/FCF Ratio	30.26	-	-	-	-	2.47
P/OCF Ratio	29.63	-	478.89	-	-	2.47
EV/Sales Ratio	6.08	6.72	6.74	6.39	7.39	28.95
EV/EBITDA Ratio	-	-	7.08	-	-	-
EV/EBIT Ratio	-	-	9.73	-	-	-
EV/FCF Ratio	33.05	-	-	-	-	9.51
Debt / Equity Ratio	0.34	0.32	0.63	2.13	1.90	1.96
Debt / EBITDA Ratio	-	-	1.11	-	-	-
Debt / FCF Ratio	3.88	-	-	-	-	0.85
Net Debt / Equity Ratio	0.24	0.28	0.57	1.92	1.51	1.80
Net Debt / EBITDA Ratio	-1.11	-1.41	1.00	-10.47	-6.26	-40.87
Net Debt / FCF Ratio	2.79	-20.82	-170.25	-51.40	-4.30	0.79
Asset Turnover	0.21	0.19	0.22	0.15	0.16	0.05
Inventory Turnover	-	-	-	-	-	0.05
Quick Ratio	1.02	0.81	1.04	0.88	1.24	0.35
Current Ratio	1.02	0.81	1.04	0.88	1.24	0.35
Return on Equity (ROE)	-30.40%	-44.40%	30.25%	-47.33%	-73.66%	-29.90%
Return on Assets (ROA)	-7.67%	-9.11%	9.65%	-5.66%	-6.47%	-1.34%
Return on Invested Capital (ROIC)	-21.80%	-24.49%	17.01%	-15.65%	-19.18%	-3.20%
Return on Capital Employed (ROCE)	-16.90%	-22.40%	20.80%	-11.60%	-12.70%	-11.30%
Earnings Yield	-12.22%	-15.96%	6.88%	-15.64%	-14.39%	-39.52%
FCF Yield	3.30%	-0.48%	-0.10%	-1.17%	-7.26%	40.43%
Buyback Yield / Dilution	-	-14.28%	-6.50%	-18.82%	-16.39%	-0.04%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.